2 Cannabis Stocks to Buy and 1 to Avoid in 2023
With no immediate hope of federal decriminalization or even the SAFE Banking Act being passed, it may be awhile until the market looks favorably toward cannabis stocks. In the meantime, investors can still find deals at relatively low prices -- as long as the companies' finances are sound enough to last what is likely to be a long shakeout period for the top U.S. multi-state operators (MSOs).
Green Thumb Industries (OTC: GTBIF), Curaleaf Holdings (OTC: CURLF) and Cresco Labs (OTC: CRLBF) are three of the largest MSOs in the U.S., but only two of them appear to be good investments right now.
The company stands out among U.S. MSOs because it's the only one that is consistently profitable, with 10 consecutive quarters of positive net income. Green Thumb closed 2020 and 2021 in the black, and despite a difficult 2022, is on track to do the same this year. Net income through nine months was $63.2 million, or $0.27 in earnings per share (EPS), up a respective 20% and 12.5% year over year.
Source Fool.com
